GREENFIELD, Ind. — Elanco Animal Health has announced the appointment of Tim Bettington as the company’s executive vice president Corporate Strategy and Market Development. He joined Elanco’s executive committee on March 20.
As Elanco shifts from the separation and stand up of the independent company and the integration of the Bayer Animal Health acquisition to an increasing focus on delivering its next era of innovation and growth, Bettington’s expertise complements the company’s existing commercial leadership team.
In his role, Bettington will be responsible for corporate strategy and market development, focused on launch readiness and preparing Elanco for. . .